Arbutus Biopharma Corp (ABUS)
2.72
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
2.72
0.00 (0.00%)
After-Hours: 18:49
Arbutus Biopharma Cash from Investing (TTM): 50.77M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 50.77M |
| September 30, 2023 | 41.23M |
| June 30, 2023 | 17.06M |
| March 31, 2023 | 1.792M |
| December 31, 2022 | -74.94M |
| September 30, 2022 | -95.74M |
| June 30, 2022 | -66.04M |
| March 31, 2022 | -90.96M |
| December 31, 2021 | -12.68M |
| September 30, 2021 | -54.53M |
| June 30, 2021 | -56.40M |
| March 31, 2021 | 5.713M |
| December 31, 2020 | -14.91M |
| September 30, 2020 | -23.76M |
| June 30, 2020 | -21.70M |
| March 31, 2020 | -35.10M |
| December 31, 2019 | 28.34M |
| September 30, 2019 | 131.94M |
| June 30, 2019 | 127.56M |
| March 31, 2019 | 132.57M |
| December 31, 2018 | -4.127M |
| September 30, 2018 | -48.20M |
| June 30, 2018 | -54.67M |
| March 31, 2018 | -71.04M |
| December 31, 2017 | 27.82M |
| Date | Value |
|---|---|
| September 30, 2017 | 27.85M |
| June 30, 2017 | 21.66M |
| March 31, 2017 | -62.35M |
| December 31, 2016 | -99.12M |
| September 30, 2016 | -101.66M |
| June 30, 2016 | -118.51M |
| March 31, 2016 | -43.45M |
| December 31, 2015 | 7.682M |
| September 30, 2015 | 10.54M |
| June 30, 2015 | 27.83M |
| March 31, 2015 | -5.077M |
| December 31, 2014 | -42.96M |
| September 30, 2014 | -44.21M |
| June 30, 2014 | -43.89M |
| March 31, 2014 | -0.859M |
| December 31, 2013 | -0.725M |
| September 30, 2013 | -0.5326M |
| June 30, 2013 | -0.4104M |
| March 31, 2013 | -0.2122M |
| December 31, 2012 | -0.012M |
| September 30, 2012 | -0.0164M |
| June 30, 2012 | -0.0146M |
| March 31, 2012 | -0.0044M |
| December 31, 2011 | -0.0604M |
| September 30, 2011 | -0.0881M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-95.74M
Minimum
Sep 2022
131.94M
Maximum
Sep 2019
-7.491M
Average
-14.91M
Median
Dec 2020
Cash from Investing (TTM) Benchmarks
| Moderna Inc | 4.206B |
| Pacira BioSciences Inc | 77.54M |
| Chimerix Inc | 70.60M |
| Karyopharm Therapeutics Inc | 7.94M |
| Corvus Pharmaceuticals Inc | 15.54M |